Quantifying the Unmet Need: Determining the Addressable Patient Population and Market Size for CAR T-Cell Therapy in India
  The emergence of CAR T-cell therapy represents one of the most significant revolutions in oncology, particularly for the treatment of hematological malignancies, and its trajectory in the Indian subcontinent is a tale of immense scientific potential struggling against massive accessibility challenges. India, with its substantial burden of blood cancers, including aggressive B-cell...
0 Commenti 0 condivisioni 2K Views 0 Anteprima